Stay updated on Daratumumab Adds to VRd in Multiple Myeloma Clinical Trial
Sign up to get notified when there's something new on the Daratumumab Adds to VRd in Multiple Myeloma Clinical Trial page.

Latest updates to the Daratumumab Adds to VRd in Multiple Myeloma Clinical Trial page
- Check6 days agoChange DetectedThe page no longer displays the primary disease term 'Multiple myeloma' and removes the related topics section including MedlinePlus Genetics. This change alters the page's disease-context labeling and access to related resources within the study overview.SummaryDifference0.1%

- Check14 days agoChange DetectedDifference0.2%

- Check21 days agoChange DetectedThe study status was updated from Active, not recruiting to Completed, indicating the trial has concluded. The record now includes a new revision (v3.5.5) and updated completion/update dates for the study.SummaryDifference0.2%

- Check28 days agoChange DetectedAdded 'Multiple myeloma' as a disease term and 'MedlinePlus Genetics' as a related topic on the page. These additions expand the page's medical context and provide direct access to related resources.SummaryDifference0.1%

- Check42 days agoChange DetectedA new PubMed publication citation was added to Publications, and the page revision tag was updated from v3.5.3 to v3.5.4.SummaryDifference0.0%

- Check57 days agoChange DetectedRevision: v3.5.3 replaces v3.5.2 on the page, indicating a minor update to the page template/metadata. No content or study data appears to be changed.SummaryDifference0.0%

Stay in the know with updates to Daratumumab Adds to VRd in Multiple Myeloma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Daratumumab Adds to VRd in Multiple Myeloma Clinical Trial page.